BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramaswamy M, Tummala R, Streicher K, Nogueira da Costa A, Brohawn PZ. The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases. Int J Mol Sci 2021;22:11286. [PMID: 34681945 DOI: 10.3390/ijms222011286] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Kishibe M, Takeda K, Honma M, Makino Y, Ishida-Yamamoto A. Effectiveness of anti-interleukin-17-receptor antibody for hydroxychloroquine-induced generalized pustular psoriasis in a patient with systemic lupus erythematosus. J Dermatol 2022. [PMID: 35838273 DOI: 10.1111/1346-8138.16514] [Reference Citation Analysis]
2 Rao J, Xu N, Sun J, Li Y, Fu F. Case Report: Interferon-Alpha-Induced Neuromyelitis Optica Spectrum Disorder. Front Neurol 2022;13:872684. [PMID: 35547376 DOI: 10.3389/fneur.2022.872684] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Martinez-arroyo O, Ortega A, Forner MJ, Cortes R. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases. Pharmaceutics 2022;14:733. [DOI: 10.3390/pharmaceutics14040733] [Reference Citation Analysis]
4 Kim M, Jeon J. Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases. IJMS 2022;23:2846. [DOI: 10.3390/ijms23052846] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Ashander LM, Lumsden AL, Dawson AC, Ma Y, Ferreira LB, Oliver GF, Appukuttan B, Carr JM, Smith JR. Infection of Human Retinal Pigment Epithelial Cells with Dengue Virus Strains Isolated during Outbreaks in Singapore. Microorganisms 2022;10:310. [DOI: 10.3390/microorganisms10020310] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]